Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3630.00    -32.00 (-0.87%)
Bid:
3630.00
Ask:
3638.00
Spread: 8.00 (0.22%)
Market Cap: £1.02b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Coronavirus (COVID-19): Update

7 Apr 2020 07:00

RNS Number : 9749I
4imprint Group PLC
07 April 2020
 

07 April 2020

4imprint Group plc ("4imprint" or the "Group")

Coronavirus (COVID-19): Update

 

4imprint today provides a further update on the effect of the COVID-19 pandemic on the Group's trading and operations.

 

In our previous COVID-19 update dated 19 March 2020, we indicated that daily order counts had reduced to around 40% of prior year, reflecting the impact of the initial spread of the disease and associated bans on travel and large gatherings. Since then, 'Safer at Home' or similar directives in nearly every state in the US and all of the UK have resulted in daily order counts that have been running at about 20% of the 2019 comparative. We anticipate that this limited level of activity is likely to continue until these restrictions begin to be lifted and economic activity starts to improve. Although our locations in Oshkosh, Wisconsin and Manchester, UK are closed, the business is running and we are able to provide service to our customers through an expanded 'work from home' capability.

 

Our people remain our first priority. We continue to operate in compliance with the latest governmental guidelines to ensure their health and safety. In line with our culture, and to enable us to capitalise rapidly on opportunities presented by a future recovery, our plan prioritises the retention of our team members. It is possible that certain government programmes will be accessible to 4imprint to assist in this regard.

 

Cost control and cash conservation are top of mind in all areas of the business. Discretionary cost, whether overhead or capital, is being tightly controlled in order to provide the business with maximum flexibility going forward. After cost of product, marketing is the largest expense in the business. The marketing portfolio has been radically re-shaped in a very short space of time, resulting in a mix that is appropriate to current circumstances in terms of both type and cost, but equally provides a firm platform to take full advantage of improving conditions when they occur.

 

4imprint remains in a strong financial position, with significant liquidity available to weather the storm and emerge in a favourable position. At the end of the first quarter of 2020 the Group had over $50m in cash balances. Given the inherent uncertainty as to how quickly markets might recover, and in order to maintain maximum flexibility, the Board has taken the prudent step of withdrawing its recommendation to pay a final dividend in May 2020. The dividend of 59.00c will no longer be paid and will result in extra cash of around $16m being available to the Group. The Board has not fundamentally changed its dividend policy, and it will reassess its position in coming months as the situation becomes clearer.

 

Whilst we are taking decisive action on cash conservation and are fully engaged in the continuous refinement and execution of our plan to ensure that the Group emerges in a strong position for the long term, we believe it is still too early to assess the duration and full economic impact resulting from COVID-19. We therefore provide no forward guidance at this stage for 2020.

 

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/ 2014. The person who arranged the release of this announcement on behalf of 4imprint was David Seekings, Chief Financial Officer of 4imprint.

 

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUPUGACUPUGMQ
Date   Source Headline
9th Jun 20261:58 pmRNSHolding(s) in Company
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.